Skip to content

Throid Dysfunction in Liver Failure and Its Eddects Upon Outcome

Thyoid Dysfucntion; Does it Affect the Short Term Outcome of Heptic Failure Patiens ?

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06179368
Enrollment
100
Registered
2023-12-21
Start date
2024-01-01
Completion date
2024-05-01
Last updated
2024-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic Encephalopathy, Hepatic Failure, Hepatic Impairment, Hypothyroidism

Keywords

Hepatic Failure, Hypothyroidism

Brief summary

Liver plays an important role in the metabolism of thyroid hormones, as it is the most important organ in the peripheral conversion of tetraiodothyronine (T4) to triiodothyronine (T3) by Type 1 deiodinase.

Detailed description

In clinical terms, cirrhosis is described as are either compensated or decompensated. Decompensation means cirrhosis complicated by one or more of the following features: jaundice, ascites, hepatic encephalopathy (HE), or bleeding varices. Ascites is the usual first sign. Hepatorenal syndrome, hyponatremia, and spontaneous bacterial peritonitis are also features of decompensation, but in these patients, ascites invariably occurs first. Compensated cirrhotic patients have none of these features. The liver plays an important role in the metabolism of thyroid hormones, as it is the most important organ in the peripheral conversion of tetraiodothyronine (T4) to T3 by Type 1 deiodinase. T4 and T3 regulate the basal metabolic rate of all cells, including hepatocytes, and thereby modulate hepatic function. The liver metabolizes the THS and regulates their systemic endocrine effects. Thyroid diseases may perturb liver function; liver disease modulates thyroid hormone metabolism; and a variety of systemic diseases affect both the organs.

Interventions

DIAGNOSTIC_TESThypothroidism

throid fuction will be evaluated on admission of hepatic failure patients, and the hypothyroid patients will be enroled in this group.

DIAGNOSTIC_TESTeuothyroid

throid fuction will be evaluated on admission of hepatic failure patients, and the euothyroid patients will be enroled in this group.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years

Inclusion criteria

\- hepatic fauiure patients

Exclusion criteria

* hypethyroid patients

Design outcomes

Primary

MeasureTime frameDescription
short termoutcome(0 to 30 days)mortality during hospitalstay

Secondary

MeasureTime frameDescription
complications(0 to 30 days)suchas renal affection, bleeding tendency ...etc

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026